ACID-FAST STAIN DEMONSTRATION LAB

LEARNING OBJECTIVES

Distinguish acid fast from non-acid-fast bacteria

Explain why some bacterial cell walls cannot be stained with traditional Gram stain

Discuss how the acid-fast can be used to identify microorganisms and why it is an important tool in clinical settings

MCCCD OFFICIAL COURSE COMPETENCIES

Identify structural characteristics of the major groups of microorganisms

Compare and contrast prokaryotic cell and eukaryotic cells

Compare and contrast the physiology and biochemistry of the various groups of microorganisms

Apply various laboratory techniques to identify types of microorganisms

BACTERIA  ALBUM LINK

The acid-fast stain was developed in 1882 by Paul Ehrlich to aid in the diagnosis of tuberculosis (TB). Ehrlich observed that stains were not absorbed by Mycobacterium unless the bacteria on the slide was heated. Once the stain was absorbed, the cell wall retained the stain even when the smear was washed with a mixture of acid and alcohol (3% hydrochloric acid and 95% ethanol).

The cell wall of bacteria Mycobacterium and Nocardia contains large amounts of glycolipids, especially mycolic acids. This unique waxy cell wall enables them to resist staining and makes them resistant to many common disinfectants. It is the mycolic acid that makes it difficult to absorb stain into the bacteria However, once the stain penetrates the cell wall (by using heat), these glycolipids prevent acid-alcohol from decolorizing the cell. Therefore, these bacteria are said to be “acid-fast”. Most bacteria, such as E. coli and Staphylococcus, lack this high mycolic acid content and are easily decolorized by the acid-alcohol. Therefore, these bacteria are described as “non-acid-fast”. They absorb the counterstain, methylene blue. The acid-fast stain is therefore a differential stain since it uses two stains to distinguish two groups of bacteria based on the mycolic acid in their cell walls. Heat and an extended stain time are used when performing the acid-fast stain to penetrate the mycolic acid in the cell walls.

Several species of Mycobacterium and Nocardia are pathogenic for animals and humans.  Mycobacterium tuberculosis causes TB and is one of the world’s deadliest diseases. According to the CDC, it is estimated that 23% of the global population has latent tuberculosis infections. 1 in 10 will go on to develop the disease. Globally, there are approximately 10 million TB infections per year. There are approximately 1.5 million TB-related deaths worldwide. This disease is the number one cause of death world-wide in patients who have AIDS.

Mycobacterium leprae causes leprosy or Hansen’s disease. Leprosy is rare in the United States with only 150-250 cases per year. In the southern United States, some armadillos are naturally infected with the bacteria that cause Hansen’s disease in people and it may be possible that they can spread it to people. However, the risk is very low and most people who have contact with armadillos are unlikely to get Hansen’s disease.

Worldwide, according to WHO, there are approximately 200,000 new cases of leprosy per year worldwide. India accounts for more than 50% of the global cases. The National Hansen’s Disease Program in Baton Rouge, Louisiana, is the only institution in the United States exclusively devoted to Hansen’s disease. The center functions as a referral and consulting center with related research and training activities. Most American patients are treated under U.S. Public Health Service grants at clinics in major cities or by private physicians.

Nocardia asteroides causes a pulmonary disease called nocardiosis which can resemble tuberculosis. In the United States, around 500-1,000 new cases of Nocardia infection occur annually. An estimated 10-15% of these patients also have HIV infection.  Nocardia can be differentiated from Mycobacterium when stained since Nocardia is usually a branching, filamentous organism and Mycobacterium is a bacilli.

PRE-ASSESSMENT

you will not perform the acid-fast stain. Please read through the acid-fast stain procedure below and complete the worksheet.

Acid-Fast Stain Procedure

Step 1. A smear of acid-fast and non-acid fast bacteria is made and heat-fixed.

Step 2. The stain procedure begins with a heat-fixed slide on the slide warmer. The primary stain carbolfuchsin is puddled on the smear for 5 minutes. The heat will melt the mycolic acid allowing all bacteria to stain pink.

Step 3The slide is transferred to the stain rack and rinsed with deionized water. Shake excess water from the slide. The slide will cool. The mycolic acid will solidify trapping the carbolfuchsin in acid-fast bacteria.

Step 4. The smear is decolorized with acid-alcohol for 2-5 seconds. The slide is rinsed with deionized water. Shake excess water from the slide. Non-acid-fast bacteria will decolorize. Acid-fast bacteria will not decolorize because the carbolfuchsin is trapped behind the solidified mycolic acid in the cell wall.

Step 5. The counterstain methylene blue stain is puddled on the smear for one minute.

Step 6. The slide is rinsed with deionized water. Shake excess water from the slide. Blot the slide. The slide is observed under oil immersion. The acid-fast stain is known as the baby stain. Acid-fast bacteria are pink. Non-acid-fast bacteria are blue.

acid-fast stain showing pink bacilli and blue bacilli bacteria
Acid-Fast stain

POST TEST

DISCOVERIES IN MICROBIOLOGY

Elizabeth Bugie Gregory

ELIZABETH BUGIE GREGORY

Elizabeth Bugie Gregory was an American microbiologist and biochemist. In 1944, Gregory, Selman Waksman, and Albert Schatz discovered the antibiotic streptomycin. Gregory was told that it was not important for her name to be on the patent as she would “one day get married and have a family”. Waksman went on the win the Nobel Prize for medicine in 1952 and took full credit for the discovery. Through a court settlement, Schatz was awarded 3% of the royalties for streptomycin and was officially recognized as co-discoverer of streptomycin. Waksman claimed that Gregory was more involved in the discovery than Schatz. Gregory was awarded 0.2% of the royalties for streptomycin.

License

Icon for the Creative Commons Attribution-NonCommercial 4.0 International License

Laboratory Exercises in Microbiology Copyright © 2022 by Anne Mason M.S. and Jill Raymond Ph.D. is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, except where otherwise noted.